[HTML][HTML] Whole transcriptome analysis of platelet concentrates during storage

H Heililahong, P Jin, H Lei, H Gu, B Qian… - Blood …, 2023 - ncbi.nlm.nih.gov
Background Platelets are anucleated blood cells and contain various RNA species. We
investigated the changes in the whole transcriptome expression profile of platelet concentrates (…

2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests

…, T Jiang, L Fan, H Lei, Y Wang, H Heililahong… - …, 2021 - Taylor & Francis
Objectives Treating red blood cells (RBCs) with dithiothreitol (DTT) is a wildly-recommended
to overcome the interference of the daratumumab (DARA) with blood compatibility testing. …

Molecular biology analysis of ABO blood group variants caused by natural chimaerism

Y Wang, Q Mou, H Lei, H Heililahong, W Zou… - Vox …, 2022 - Wiley Online Library
Background and Objectives The chimaerism phenomenon constitutes a significant
mechanism underlying ABO phenotype discrepancies; however, its detection has technical …

2-mercaptoethanol (2-ME)-based IATs or polybrene method mitigates the interference of anti-CD38 immunotherapy on blood compatibility tests

…, L Chen, T Jiang, L Fan, H Lei, Y Wang, H Heililahong… - medRxiv, 2020 - medrxiv.org
Background Treating red blood cells (RBCs) with dithiothreitol (DTT) is a wildly-recommended
to overcome the interference of anti-CD38 immunotherapy with blood compatibility testing…

F(ab′)2 Fragments to Overcome Daratumumab Interference in Transfusion Tests

K Selleng, PD Gebicka, T Thiele - New England Journal of …, 2018 - Mass Medical Soc
False Positive Coombs’ Tests and Daratumumab Daratumumab is an effective agent in
multiple myeloma. Its binding of CD38 on red cells causes false positive results on Coombs’ …